FACA

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”

HHS - 21491 - Advisory Board on the Demonstration of a Bundled Case-Mix Adjusted Payment System for End Stage Renal Disease Services - Statutory (Congress Created)

GENERAL INFORMATION

Committee Name	Advisory Board on the Demonstration of a Bundled Case-Mix Adjusted Payment System for End Stage Renal Disease Services	Agency Name	Department of Health and Human Services
Fiscal Year	2008	Committee Number	21491
Original Establishment Date	5/11/2004	Committee Status	Terminated
Actual Termination Date	8/6/2008	Committee URL	http://www.cms.hhs.gov/FACA/09_AdvisoryBoardont...
New Committee This FY	No	Presidential Appointments*	No
Terminated This FY	Yes	Max Number of Members*	12
Current Charter Date	11/27/2006	Designated Fed Officer Position Title*	Designated Federal Official
Date Of Renewal Charter	11/27/2008	Designated Federal Officer Prefix
Projected Termination Date	12/31/2008	Designated Federal Officer First Name*	Pamela
Exempt From Renewal*	No	Designated Federal Officer Middle Name
Specific Termination Authority	Section 623e of MMA Public Law 108-173	Designated Federal Officer Last Name*	Morrow
Establishment Authority*	Statutory (Congress Created)	Designated Federal Officer Suffix
Specific Establishment Authority*	Section 623e of MMA Public Law 108-173	Designated Federal Officer Phone*	(410) 786-2461
Effective Date Of Authority*	5/11/2004	Designated Federal Officer Fax*	410-786-2461
Exempt From EO 13875 Discretionary Cmte		Designated Federal Officer Email*	pamela.morrow@cms.hhs.gov
Committee Type*	Continuing
Presidential*	No
Committee Function*	Other Committee

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*	Terminate
Legislation to Terminate Required	Yes
Legislation Status	Enacted
How does cmte accomplish its purpose?*	The Advisory Committee accomplishes its purpose by using the diverse expertise and perspectives of its members to advise and make recommendations to the Secretary of HHS and the Administrator of the Centers for Medicare & Medicaid Services (CMS) with respect to the establishment and operation of a demonstration to test a bundled case-mix adjusted payment system for ESRD services. Prior to the implementation of the demonstration the Advisory Board shall study and make recommendations on issues including the services to be included in the demonstration bundle; patient characteristics to be included in the case-mix adjusted demonstration payment system; quality incentives and standards to be utilized in the demonstration; and selection criteria for demonstration organizations.
How is membership balanced?*	The Advisory Board on the Demonstration of a Bundled Case-Mix Adjusted Payment System for End Stage Renal Disease Services will consist of 11 members composed of members with expertise in technical areas related to ESRD. The Chair shall either be appointed from among the 11 members of a Federal official will be designated serve as the Chair. The members and the Chair shall be selected by the Secretary, or designee, and include representatives of patient organizations; individuals with expertise in ESRD dialysis services, such as clinicians, economist and researchers; the Medicare Payment Advisory Commission, established under section 1805 of the Social Security Act (42 USC 1395b-6); The National Institutes of Health; Network Organizations under section 1881 ( c) of the Social Security Act (42 USC 1395rr( c); Medicare contractors to monitor quality of care; and representatives of providers of services and renal dialysis facilities furnishing ESRD services.
How frequent & relevant are cmte mtgs?*	Meetings shall be held no more than four times a year. If the Chair is selected from among the 11 members, the Chair will call a meeting with the advance approval of a Government official who shall also approve the agenda and be present at all meetings. If the Chair is a Government official, the Government official will call the meetings, approve the agenda and serve as the Government official at the meetings. The panel meetings are necessary to discuss panel issues, provide advice and/or make recommendations to the Secretary Department of Health and Human Services and to the Administrator Centers for Medicare & Medicaid Services.
Why advice can't be obtained elsewhere?*	The Medicare Prescription Drug Improvement and Modernization Act of 2003 (MMA) Section 623 (e) P.L. 108-173 mandates the Secretary of HHS to establish an advisory board to provide advice and recommendations with respect to the establishment and operation of a demonstration to test a bundled case-mix adjusted payment system for end stage renal disease (ESRD) services. The demonstration is to be conducted for the 3-year period beginning on January 1, 2006.
Why close or partially close meetings?	Meetings are not closed. All meetings shall be open to the public except as determined otherwise by the Secretary or other official to whom the authority has been delegated. Notices of meetings are given to the public in the Federal Register, and there will be records of the meeting proceedings kept, as required by applicable laws and departmental regulations. In the event that a portion of a meeting is closed to the public, a report will be prepared that contains at a minimum a list of members and their business addresses, the Panel’s function, dates and places of meetings, and a summary of Panel activities and recommendations made during the fiscal year. A copy of the report will be provided to the Department Committee Management Officer.
Recommendation Remarks	This committee provides recommendations throughout the year and does not do a yearly report. This committee did not meet during the 07 or 08 fiscal year and was terminated 8/6/08.

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*	Yes	Action Reorganize Priorities*	No
Outcome Trust In Government	Yes	Action Reallocate Resources	No
Outcome Major Policy Changes	No	Action Issued New Regulations	No
Outcome Advance In Scientific Research	No	Action Proposed Legislation	No
Outcome Effective Grant Making	No	Action Approved Grants Or Other Payments	No
Outcome Improved Service Delivery	Yes	Action Other	No
Outcome Increased Customer Satisfaction	Yes	Action Comment	NA
Outcome Implement Laws/Reg Requirements	No	Grants Review*	No
Outcome Other	No	Number Of Grants Reviewed	0
Outcome Comment	NA	Number Of Grants Recommended	0
Cost Savings*	Unable to Determine	Dollar Value Of Grants Recommended	$0.00
Cost Savings Comment	NA	Grants Review Comment	NA
Number Of Recommendations*	0	Access Contact Designated Fed. Officer*	Yes
Number Of Recommendations Comment	Formal recommendations have not been made yet.	Access Agency Website	Yes
% of Recs Fully Implemented*	0.00%	Access Committee Website	Yes
% of Recs Fully Implemented Comment	The demonstration is not at the implementation stage yet.	Access GSA FACA Website	Yes
% of Recs Partially Implemented*	0.00%	Access Publications	No
% of Recs Partially Implemented Comment	This percentage cannot be determined at this time.	Access Other	No
Agency Feedback*	Not Applicable	Access Comment	N/A
Agency Feedback Comment*	NA	Narrative Description*	The Secretary of Health and Human Services is mandated by section 623(e) of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) (PL 108-173) to establish an Advisory Board on the demonstration of a bundled case-mix adjusted payment system for end stage renal disease (ESRD) services. The Advisory Board is to provide advice and recommendations with respect to the establishment and operation of such demonstration.

COSTS

Payments to Non-Federal Members*	$0.00	Est Payments to Non-Fed Members Next FY*	$0.00
Payments to Federal Members*	$0.00	Est. Payments to Fed Members Next FY*	$0.00
Payments to Federal Staff*	$0.00	Estimated Payments to Federal Staff*	$0.00
Payments to Consultants*	$0.00	Est. Payments to Consultants Next FY*	$0.00
Travel Reimb. For Non-Federal Members*	$0.00	Est Travel Reimb Non-Fed Members nextFY*	$0.00
Travel Reimb. For Federal Members*	$0.00	Est Travel Reimb For Fed Members*	$0.00
Travel Reimb. For Federal Staff*	$0.00	Est. Travel Reimb to Fed Staff Next FY*	$0.00
Travel Reimb. For Consultants*	$0.00	Est Travel Reimb to Consultants Next FY*	$0.00
Other Costs	$0.00	Est. Other Costs Next FY*	$0.00
Total Costs	$0.00	Est. Total Next FY*	$0.00
Date Cost Last Modified		Est. Fed Staff Support Next FY*	0.50
Federal Staff Support (FTE)*	0.50	Est Cost Remarks
Cost Remarks

Interest Areas

No interest areas selected for this committee.

Custom Links

Committee Level Reports